How does personal utility depend on clinical setting? Evidence from 3 cohorts
Elise Poole(Hospital for Sick Children), Anita Villani(University of Toronto), David Chitayat(Mount Sinai Hospital), Linlea Armstrong(University of British Columbia), Iskra Peltekova(Hospital for Sick Children), Stephanie Luca(Hospital for Sick Children), Rebecca Deyell(University of British Columbia), Melissa Maio(York Central Hospital), Maureen E. Smith(Northwestern University), Robin Z. Hayeems(University of Toronto), Rachel Silver(Mount Sinai Hospital), Patricia Birch(University of British Columbia), Lesleigh S. Abbott(Children's Hospital of Eastern Ontario), Sarah L. Sawyer(Children's Hospital of Eastern Ontario), Ronni Teitelbaum(York Central Hospital), Catherine Goudie(Montreal Children's Hospital), Anne‐Marie Laberge(Centre Hospitalier Universitaire Sainte-Justine), Wendy J. Ungar(University of Toronto), Daniel Assamad(University of Toronto), Avram Denburg(Hospital for Sick Children), June Carroll(Sinai Health System), Joyce Yan(Hospital for Sick Children), Becky Quinlan(HealthPartners), Bowen Xiao(Hospital for Sick Children), Kym M. Boycott(Children's Hospital of Eastern Ontario), Lauren Chad(Hospital for Sick Children), Alison M. Elliott(Winnipeg Regional Health Authority)
Cited by 3
Related Papers
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
|Genetics in Medicine|2013|741
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617